Foresite Capital Management IV, LLC
An institutional investment manager in WEST HOLLYWOOD, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1704132.
- Reported value$290.2m
- Positions6
Holdings: 6 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Pharvaris N.V. | COM | N69605108 | 165 | 57.0% | 4,778,581 | Unchanged | |
| Cytokinetics IncCYTK | COM | 23282W605 | 60.9 | 21.0% | 714,695 | Added+211,400 | |
| Eikon Therapeutics, Inc.EIKN | COM | 282564103 | 25.4 | 8.7% | 1,943,682 | Unchanged | |
| Relay Therapeutics, Inc.RLAY | COM | 75943R102 | 23.4 | 8.1% | 1,250,000 | Added+250,000 | |
| Xenon Pharmaceuticals Inc.XENE | COM | 98420N105 | 9.7 | 3.3% | 160,000 | Unchanged | |
| Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 5.6 | 1.9% | 150,000 | New+150,000 |
Sold out: 3 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Alector, Inc.ALEC | COM | 014442107 | 0.0 | 0.0% | 0 | Sold out−3,887,200 | |
| Lyell Immunopharma, Inc.LYEL | COM | 55083R203 | 0.0 | 0.0% | 0 | Sold out−800,399 | |
| Maze Therapeutics, Inc.MAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Sold out−156,901 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-097103 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.